Esperion Therapeutics ESPR Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Esperion Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's asset turnover?
- Esperion Therapeutics (ESPR) reported asset turnover of 1.1× in Q1 2026.
- How has Esperion Therapeutics's asset turnover changed year-over-year?
- Esperion Therapeutics's asset turnover increased by 42.8% year-over-year, from 0.7× to 1.1×.
- What is the long-term trend for Esperion Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Esperion Therapeutics's asset turnover has grown at a 4.4% compound annual growth rate (CAGR), from 0.8× to 1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.